Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novel conjugate for liver fibrosis

Nov. 22, 2005

New data on the effects of valopicitabine in hepatitis C

Nov. 22, 2005

Promising results reported from a phase Ib trial on VX-950 in hepatitis C

Nov. 21, 2005

HCV-ABXTL-68 shows antiviral activity in liver transplant recipients

Nov. 21, 2005

GNS-037: A novel HCV entry inhibitor

Nov. 18, 2005

Clinical evidence supports the use of CpG-10101 in hepatitis C

Nov. 18, 2005

Good safety and pharmacokinetic data reported for ANA-975 in monkeys and humans

Nov. 18, 2005

Update on SCH-503034 in the treatment of hepatitis C

Nov. 17, 2005

Recent patents describe novel anti-hepatitis agents

Nov. 17, 2005

Novel FXR activator shows promise in the treatment of hepatic fibrosis

Nov. 17, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....